全文获取类型
收费全文 | 19099篇 |
免费 | 1622篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 267篇 |
儿科学 | 676篇 |
妇产科学 | 458篇 |
基础医学 | 2735篇 |
口腔科学 | 275篇 |
临床医学 | 2671篇 |
内科学 | 4215篇 |
皮肤病学 | 230篇 |
神经病学 | 1785篇 |
特种医学 | 434篇 |
外国民族医学 | 2篇 |
外科学 | 1743篇 |
综合类 | 194篇 |
一般理论 | 22篇 |
预防医学 | 2358篇 |
眼科学 | 235篇 |
药学 | 1209篇 |
中国医学 | 17篇 |
肿瘤学 | 1236篇 |
出版年
2023年 | 187篇 |
2022年 | 215篇 |
2021年 | 463篇 |
2020年 | 376篇 |
2019年 | 547篇 |
2018年 | 558篇 |
2017年 | 490篇 |
2016年 | 491篇 |
2015年 | 542篇 |
2014年 | 668篇 |
2013年 | 999篇 |
2012年 | 1310篇 |
2011年 | 1288篇 |
2010年 | 742篇 |
2009年 | 654篇 |
2008年 | 1104篇 |
2007年 | 1103篇 |
2006年 | 1047篇 |
2005年 | 944篇 |
2004年 | 885篇 |
2003年 | 810篇 |
2002年 | 755篇 |
2001年 | 353篇 |
2000年 | 252篇 |
1999年 | 266篇 |
1998年 | 180篇 |
1997年 | 129篇 |
1996年 | 136篇 |
1995年 | 127篇 |
1994年 | 127篇 |
1993年 | 104篇 |
1992年 | 200篇 |
1991年 | 224篇 |
1990年 | 203篇 |
1989年 | 224篇 |
1988年 | 169篇 |
1987年 | 166篇 |
1986年 | 171篇 |
1985年 | 164篇 |
1984年 | 123篇 |
1983年 | 132篇 |
1982年 | 100篇 |
1981年 | 66篇 |
1980年 | 71篇 |
1979年 | 103篇 |
1978年 | 81篇 |
1977年 | 66篇 |
1976年 | 59篇 |
1974年 | 57篇 |
1973年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 690 毫秒
1.
2.
3.
Anne-Sophie Worm Fenger Markus Harboe Olsen Maria Louise Fabritius Christian Gunge Riberholt Kirsten Møller 《Acta anaesthesiologica Scandinavica》2023,67(2):240-247
Background
Hyperglycaemia is common in patients with acute brain injury admitted to an intensive care unit (ICU). Many studies have found associations between development of hyperglycaemia and increased mortality in hospitalised patients. However, the optimal target for blood glucose control is unknown. We want to conduct a systematic review with meta-analysis and trial sequential analysis to explore the beneficial and harmful effects of restrictive versus liberal glucose control on patient outcomes in adults with severe acute brain injury.Methods
We will systematically search medical databases including CENTRAL, Embase, MEDLINE and trial registries. We will search the following websites for ongoing or unpublished trials: http://www.controlled-trials.com/ , http://www.clinicaltrials.gov/ , www.eudraCT.com , http://centerwatch.com/ , The Cochrane Library's CENTRAL, PubMed, EMBASE, Science Citation Index Expanded and CINAHL. Two authors will independently review and select trials and extract data. We will include randomised trials comparing levels of glucose control in our analyses and observational studies will be included to address potential harms. The primary outcomes are defined as all-cause mortality, functional outcome and health-related quality of life. Secondary outcomes include serious adverse events including hypoglycaemia, length of ICU stay and duration of mechanical ventilation, and explorative outcomes including intracranial pressure and infection. Trial Sequential Analysis will be used to investigate the risk of type I error due to repetitive testing and to further explore imprecision. Quality of trials will be evaluated using the Cochrane Risk of Bias tool, and quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.Discussion
The results of the systematic review will be disseminated through peer-reviewed publication. With the review, we hope to inform future randomised clinical trials and improve clinical practice. 相似文献4.
Louise Danielsson RPT MSc Susanne Rosberg RPT PhD 《Scandinavian journal of caring sciences》2015,29(3):501-509
Although depression is associated to physical discomfort, meanings of the body in depression are rarely addressed in clinical research. Drawing on the concept of the lived body, this study explores depression as an embodied phenomenon. Using a hermeneutic phenomenological approach, the analysis of narrative‐based interviews with 11 depressed adults discloses a thematic structure of an embodied process of an ambiguous striving against fading. Five subthemes elicit different dimensions of this process, interpreted as disabling or enabling: feeling estranged, feeling confined, feeling burdensome, sensing life and seeking belongingness. In relation to clinical practice, we suggest that the interdisciplinary team can focus on enhancing the enabling dimensions, for example through guided physical activities to support the patient to feel more alive, capable and connected. Moreover, we suggest that the treatment process benefits from an increased awareness of the ambiguity in the patient's struggle, acknowledging both destructive and recharging elements of the withdrawing, and the perceived conflict in‐between. 相似文献
5.
6.
7.
Anders Elm Pedersen Esben Gjerløff Wedebye Schmidt Jesper Freddie Sørensen Carsten Faber Boye Schnack Nielsen Kim Holmstrøm Silje Haukali Omland Peter Tougaard Søren Skov Bo Bang 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(7):547-555
TL1A is a TNF‐like cytokine which has been shown to co‐stimulate TH1 and TH17 responses during chronic inflammation. The expression of this novel cytokine has been investigated in inflammatory disorders like rheumatoid arthritis and inflammatory bowel disease, but little is known about expression and induction in psoriasis. Indeed, the pathogenesis in psoriasis is still not fully understood and it is speculated that cytokines other than TNF‐α are important in subsets of patients. Also, for patients with severe disease that are treated with systemic anti‐TNF‐α blockade, novel candidates to be used as disease and response biomarkers are of high interest. Here, we demonstrate TL1A expression in biopsies from psoriatic lesions. Also, we investigated spontaneous and induced TL1A secretion from PBMCs and blood levels from a cohort of psoriasis patients. Here, increased spontaneous secretion from PBMCs was observed as compared to healthy controls and a small subset of patients had highly elevated TL1A in the blood. Interestingly, activation of PBMCs with various cytokines showed a decreased sensitivity for TL1A activation in psoriasis patients compared to healthy controls.TL1A levels in blood and biopsies could not be correlated with disease activity with this patient cohort. Thus, additional large‐scale studies are warranted to investigate TL1A as a biomarker. 相似文献
8.
9.
10.